Buccal Fat Reconstruction for Tonsil Cancer
(BOLT Trial)
Trial Summary
What is the purpose of this trial?
The goal of this randomized clinical trial is to determine the pain intensity during rest and swallowing in patients undergoing transoral robotic surgery for tonsil lesions with and without buccal fat reconstruction. The main question it aims to answer is: does buccal fat after transoral robotic surgery reduce pain after surgery? Additional questions to be explored include if there is a difference in swallowing, complication rates, pain medication usage, and feeding tube usage. Participants will be asked to rate their pain and swallowing on a visual analogue scale after surgery. The group will be compared compared to a control group that undergoes transoral robotic surgery without buccal fat reconstruction.
Research Team
Christopher Yao, MD FRCSC
Principal Investigator
University Health Network, Toronto
John R de Almeida, MD MSc FRCSC
Principal Investigator
University Health Network, Toronto
Michael Xie, MD FRCSC
Principal Investigator
University Health Network, Toronto
Rosemary Martino, Ma MSc PhD
Principal Investigator
University Health Network, Toronto
Eligibility Criteria
This trial is for patients with certain throat cancers, including oropharynx and tonsil cancer, who are undergoing transoral robotic surgery. Participants must be able to provide pain and swallowing assessments post-surgery. Specific inclusion and exclusion criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo transoral robotic surgery with or without buccal fat reconstruction
Postoperative Monitoring
Participants' pain, swallowing, and other outcomes are assessed at multiple time points post-surgery
Follow-up
Participants are monitored for surgical complications and other secondary outcomes
Treatment Details
Interventions
- Buccal Fat Reconstruction
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor